论文部分内容阅读
目的:评价2种抗生素治疗小儿肺炎的经济学效果。方法:将100例肺炎患儿随机分为头孢唑林组与头孢呋辛组,运用成本-效果分析法进行评价。结果:头孢唑林组与头孢呋辛组的治愈率分别为98.0%、96.0%(P>0.05);成本分别为915.70、1036.80元(P<0.05);成本-效果比分别为934.39、1080.00。2组均未发生与治疗药物相关的严重不良反应。结论:头孢唑林钠治疗小儿肺炎比头孢呋辛钠经济。
Objective: To evaluate the economic effect of two kinds of antibiotics in children with pneumonia. Methods: One hundred children with pneumonia were randomly divided into cefazolin group and cefuroxime group, and the cost-effectiveness analysis was used to evaluate them. Results: The cure rates of cefazolin and cefuroxime group were 98.0% and 96.0% respectively (P> 0.05). The costs were 915.70 and 1036.80 yuan respectively (P <0.05). The cost-effectiveness ratios were 934.39 and 1080.00 respectively. None of the two groups experienced serious adverse drug reactions. Conclusion: Cefazolin sodium treatment of children with pneumonia than cefuroxime sodium economy.